Retrieve available abstracts of 136 articles: HTML format
Single Articles
July 2025
KHER S No cancer left behind: Systematic follow-up systems are essential to improve
adherence to lung cancer screening.
J Thorac Cardiovasc Surg. 2025 Jul 5:S0022-5223(25)00529. PubMed
INAN GA, Aksakal AK, Ayrak FB, Ergiden C, et al Interpreting survival comparisons in stage III non-small cell lung cancer:
Performance bias and the need for subgroup-specific analysis.
J Thorac Cardiovasc Surg. 2025 Jul 2:S0022-5223(25)00473. PubMed
ZERVOS M, Park BJ, Marshall MB, Wee JO, et al Robotic-assisted single-port system for pulmonary lobectomy: A prospective
feasibility study.
J Thorac Cardiovasc Surg. 2025;170:54-60. PubMedAbstract available
April 2025
BASKIN AS, Funk EC, Francescatti AB, Sinco BR, et al Early Compliance with Lung Cancer Lymph Node Standard 5.8: An Analysis of 2022
and 2023 Commission on Cancer Site Reviews.
J Thorac Cardiovasc Surg. 2025 Apr 29:S0022-5223(25)00340. PubMedAbstract available
EISENBERG MA, Werner R, Ries S, Hofstetter WL, et al Extent of Resection in Surgically Resected Stage IV Non-Small-Cell Lung Cancer:
Results from Two Tertiary Referral Centers.
J Thorac Cardiovasc Surg. 2025 Apr 23:S0022-5223(25)00327. PubMedAbstract available
LI H, Pezeshkian F, Xie Y, Mazzola E, et al Lung Cancer Recurrence after Neoadjuvant Immunotherapy.
J Thorac Cardiovasc Surg. 2025 Apr 20:S0022-5223(25)00328. PubMedAbstract available
WILLIAMS JE, Jacobs RC, Savitch SL, Hollenbeck ME, et al Provider and Procedural Factors Associated with Guideline-Concordant Lymph Node
Sampling in Lung Cancer Resection.
J Thorac Cardiovasc Surg. 2025 Apr 17:S0022-5223(25)00304. PubMedAbstract available
ANTONOFF MB, Gay CM Timing of local consolidative pulmonary resection for oncogene-driven stage IV
lung cancer.
J Thorac Cardiovasc Surg. 2025 Apr 3:S0022-5223(25)00281. PubMed
MITRA S, Jang HJ, Kuncheria A, Kang SW, et al Soluble mesothelin-related peptide as a prognosticator in pleural mesothelioma
patients receiving checkpoint immunotherapy.
J Thorac Cardiovasc Surg. 2025;169:1082-1095. PubMedAbstract available
HUANG J, Tan KS, Altorki N, Antonoff M, et al Initial patient characteristics of Thoracic Surgical Oncology Group 102: A
multicenter prospective registry of active surveillance in patients with multiple
ground-glass opacities.
J Thorac Cardiovasc Surg. 2025;169:1100-1107. PubMedAbstract available
CAO H, Zhu W, Tang H, Deng C, et al Dissecting the clinicopathologic, genomic, and prognostic significance of
anaplastic lymphoma kinase rearrangement in resected lung adenocarcinoma.
J Thorac Cardiovasc Surg. 2025;169:1143-1152. PubMedAbstract available
STANIFER BP, Harris S, Nguyen SN, Vinogradsky AV, et al Surgical management of pleural complications in lymphangioleiomyomatosis.
J Thorac Cardiovasc Surg. 2025;169:1133-1141. PubMedAbstract available
March 2025
CURRY J, Pompili C Moving toward better outcomes: Time to be active before lung cancer surgery.
J Thorac Cardiovasc Surg. 2025 Mar 11:S0022-5223(25)00123. PubMed
Commentator Discussion: Time to surgery in early-stage non-small cell lung cancer
(NSCLC): Defining the optimal diagnosis-to-resection interval to reduce
mortality.
J Thorac Cardiovasc Surg. 2025 Mar 6:S0022-5223(25)00104. PubMed
CHO AR, Najafi T, Ramanakumar AV, Ferri L, et al The Effect of Multimodal Prehabilitation on Postoperative Outcomes in Lung Cancer
Surgery.
J Thorac Cardiovasc Surg. 2025 Mar 3:S0022-5223(25)00173. PubMedAbstract available
February 2025
DENG H, Yu Z, Pan Y, Huang Y, et al SEGMENTECTOMY/WEDGE resection following neoadjuvant/induction immunochemotherapy
in non-small cell lung cancer: Is it justified?
J Thorac Cardiovasc Surg. 2025 Feb 7:S0022-5223(25)00008. PubMed
FICK CN, Dunne EG, Toumbacaris N, Tan KS, et al Late recurrence of completely resected stage I to IIIA lung adenocarcinoma.
J Thorac Cardiovasc Surg. 2025;169:445-453. PubMedAbstract available
FICK CN, Dunne EG, Vanstraelen S, Toumbacaris N, et al High-risk features associated with recurrence in stage I lung adenocarcinoma.
J Thorac Cardiovasc Surg. 2025;169:436-444. PubMedAbstract available
PEZESHKIAN F, Leo R, McAllister MA, Singh A, et al Predictors of prolonged hospital stay after segmentectomy.
J Thorac Cardiovasc Surg. 2025;169:420-426. PubMedAbstract available
January 2025
HUANG X, Zhu L, Hu J Surgery for lung cancer: Time waits for no one.
J Thorac Cardiovasc Surg. 2025 Jan 31:S0022-5223(25)00005. PubMed
XU MM, Cerullo M Commentary: Missing 100% of the cancers you don't look for: pitfalls and
performance of lung cancer screening efforts in a real-world setting.
J Thorac Cardiovasc Surg. 2025 Jan 8:S0022-5223(25)00003. PubMed
THERRIAULT CS, Kim AW Commentary: The Ticking Lung Cancer Clock.
J Thorac Cardiovasc Surg. 2025 Jan 8:S0022-5223(25)00004. PubMed
BOTT MJ, Toumbacaris N, Tan KS, Husta BC, et al Characterizing a learning curve for robotic-assisted bronchoscopy: Analysis of
skills acquisition in a high-volume academic center.
J Thorac Cardiovasc Surg. 2025;169:269-278. PubMedAbstract available
December 2024
FUKUI M, Suzuki K Reply: Prognostic significance of preoperative exercise tolerance in patients
with early-stage lung cancer.
J Thorac Cardiovasc Surg. 2024 Dec 27:S0022-5223(24)01133. PubMed
KOYLU B, Guven DC Controversial influence of adjuvant immunotherapy in survival outcomes for
patients with non-small cell lung cancer with major/complete pathologic response.
J Thorac Cardiovasc Surg. 2024 Dec 26:S0022-5223(24)01186. PubMed
DE PERROT M Reply: The pulmonary sulcus phenomenon in lung cancer invading the chest wall.
J Thorac Cardiovasc Surg. 2024 Dec 23:S0022-5223(24)01095. PubMed
ALTORKI N, Wang X, Damman B, Mentlick J, et al Corrigendum to: Lobectomy, segmentectomy, or wedge resection for peripheral
clinical T1aN0 non-small cell lung cancer: A post hoc analysis of CALGB 140503
(Alliance)" [The Journal of Thoracic and Cardiovascular Surgery Volume 167, Issue
1, January 202
J Thorac Cardiovasc Surg. 2024 Dec 20:S0022-5223(24)01142. PubMed
PARIKH MJ, Chai LF, Russo MG, Tompkins AK, et al Dismal Adherence to Lung Cancer Screening in a Diverse Urban Population.
J Thorac Cardiovasc Surg. 2024 Dec 13:S0022-5223(24)01136. PubMedAbstract available
ZOLFAGHARI EJ, Ayoade O, Antonoff MB Barriers to fitness: Disparities in preoperative exercise access for patients
with lung cancer.
J Thorac Cardiovasc Surg. 2024 Dec 13:S0022-5223(24)01096. PubMed
TUPPER HI, Sarovar V, Banks KC, Schmittdiel JA, et al Time to Surgery in Early-Stage Non-Small Cell Lung Cancer (NSCLC): Defining the
Optimal Diagnosis-to-Resection Interval to Reduce Mortality.
J Thorac Cardiovasc Surg. 2024 Dec 12:S0022-5223(24)01125. PubMedAbstract available
ZHU W, Han H, Ma Z, Cao H, et al Prognostic value of KRAS G12V mutation in lung adenocarcinoma stratified by
stages and radiological features.
J Thorac Cardiovasc Surg. 2024;168:1525-1537. PubMedAbstract available
November 2024
ZHAO ZR, Yan WP, Yu XY, Zhang JB, et al Adjuvant Immunotherapy Does Not Improve Survival in Non-small Cell Lung Cancer
with Major/Complete Pathological Response after Induction Immunotherapy.
J Thorac Cardiovasc Surg. 2024 Nov 29:S0022-5223(24)01109. PubMedAbstract available
FERRARIS VA Commentary: On 'Gender, Race, and Ethnicity in Lung Cancer Clinical Trial
Participation'.
J Thorac Cardiovasc Surg. 2024 Nov 10:S0022-5223(24)01029. PubMed
UDELSMAN BV, Bedrosian CK, Kawaguchi ES, Ding L, et al Living on the Edge: Role of Adjuvant Therapy After Resection of Primary Lung
Cancer Within 2 Millimeters of a T-Stage Cutoff.
J Thorac Cardiovasc Surg. 2024 Nov 7:S0022-5223(24)01021. PubMedAbstract available
Discussion to: Early real-world experience monitoring circulating tumor DNA in
resected early-stage non-small cell lung cancer.
J Thorac Cardiovasc Surg. 2024;168:1360-1361. PubMed
Discussion to: Should sampling of 3 N2 stations be a quality metric for curative
resection of stage I lung cancer?
J Thorac Cardiovasc Surg. 2024;168:1346-1348. PubMed
WANG S, Meng F, Chen P, Lv Y, et al Cell-free DNA assay for malignancy classification of high-risk lung nodules.
J Thorac Cardiovasc Surg. 2024;168:e140-e175. PubMedAbstract available
October 2024
GALVAING G, Drevet G, Tricard J, Gregoire J, et al Lung cancer invading the chest wall: The role of site of chest wall invasion.
J Thorac Cardiovasc Surg. 2024 Oct 17:S0022-5223(24)00826. PubMed
RABINOVICH EP, Martin LW Getting Patients to Adjuvant Therapy after Lung Cancer Resection: ERAS Protocols
and Return to Intended Oncologic Therapy.
J Thorac Cardiovasc Surg. 2024 Oct 10:S0022-5223(24)00916. PubMed
HUTCHINGS H, Boyajian H, Okereke I Reply: Achieving environmental justice will reduce lung cancer health
disparities.
J Thorac Cardiovasc Surg. 2024 Oct 9:S0022-5223(24)00766. PubMed
YUAN W, Huang R, Yang Z Will salvage surgery lead to a paradigm shift in the treatment of stage IV lung
cancer?
J Thorac Cardiovasc Surg. 2024 Oct 4:S0022-5223(24)00808. PubMed
LEE JM Neoadjuvant, perioperative, or adjuvant immunotherapy in resectable non-small
cell lung cancer: How do I choose? Importance of immune biomarkers and molecular
testing.
J Thorac Cardiovasc Surg. 2024;168:1281-1288. PubMed
YANG Z, Wang S, Yang H, Jiang Y, et al Treatment patterns and clinical outcomes of patients with resectable non-small
cell lung cancer receiving neoadjuvant immunochemotherapy: A large-scale,
multicenter, real-world study (NeoR-World).
J Thorac Cardiovasc Surg. 2024;168:1245-1258. PubMedAbstract available
September 2024
KANUPARTHY M, Kanuparthy S, Harris DD, Broadwin M, et al Gender, Race, and Ethnicity in Lung Cancer Clinical Trial Participation: Analysis
of 253,845 Patients From 2002 - 2021.
J Thorac Cardiovasc Surg. 2024 Sep 28:S0022-5223(24)00893. PubMedAbstract available
FERRARI-LIGHT D, Merritt RE, D'Souza D, Ferguson MK, et al Evaluating ChatGPT as a Patient Resource for Frequently Asked Questions about
Lung Cancer Surgery - A Pilot Study.
J Thorac Cardiovasc Surg. 2024 Sep 24:S0022-5223(24)00837. PubMedAbstract available
BRUNELLI A, Antonoff MB, Petersen RH, Stiles BM, et al Surgeon preferences for self-treatment in locally advanced non-small cell lung
cancer: Would we practice what we preach?
J Thorac Cardiovasc Surg. 2024 Sep 19:S0022-5223(24)00526. PubMed
ADACHI H, Ito H, Nagashima T, Isaka T, et al Mediastinal lymph node dissection in segmentectomy for peripheral c-stage IA (=2
cm) non-small-cell lung cancer.
J Thorac Cardiovasc Surg. 2024 Sep 9:S0022-5223(24)00786. PubMedAbstract available
CHEN H, Kim AW, Hsin M, Shrager JB, et al The 2023 American Association for Thoracic Surgery (AATS) Expert Consensus
Document: Management of subsolid lung nodules.
J Thorac Cardiovasc Surg. 2024;168:631-647. PubMedAbstract available
Discussion to: Oncological characteristics of EGFR-mutated clinical stage IA lung
adenocarcinoma with radiologically pure-solid appearance.
J Thorac Cardiovasc Surg. 2024;168:697-698. PubMed
Discussion to: Digital spatial profiling to predict recurrence in grade 3 stage I
lung adenocarcinoma.
J Thorac Cardiovasc Surg. 2024;168:658-659. PubMed
HATTORI A, Matsunaga T, Fukui M, Tomita H, et al Oncological characteristics of epidermal growth factor receptor-mutated clinical
stage IA lung adenocarcinoma with radiologically pure-solid appearance.
J Thorac Cardiovasc Surg. 2024;168:685-696. PubMedAbstract available
CHANG SH, Mezzano-Robinson V, Zhou H, Moreira A, et al Digital spatial profiling to predict recurrence in grade 3 stage I lung
adenocarcinoma.
J Thorac Cardiovasc Surg. 2024;168:648-657. PubMedAbstract available
August 2024
HOODA Z, Antonoff MB Air-Quality variability highlights disparities in lung cancer.
J Thorac Cardiovasc Surg. 2024 Aug 24:S0022-5223(24)00674. PubMed
CHU NQ, Tan KS, Dycoco J, Adusumilli PS, et al Determinants of successful minimally invasive surgery (MIS) for resectable
non-small cell lung cancer (NSCLC) after neoadjuvant therapy.
J Thorac Cardiovasc Surg. 2024 Aug 19:S0022-5223(24)00696. PubMedAbstract available
Commentator Discussion: Influence of air quality on lung cancer in people who
have never smoked.
J Thorac Cardiovasc Surg. 2024 Aug 12:S0022-5223(24)00650. PubMed
July 2024
Commentator Discussion: Preoperatively predicting survival outcome for clinical
stage IA pure-solid non-small cell lung cancer by radiomics-based machine
learning.
J Thorac Cardiovasc Surg. 2024 Jul 30:S0022-5223(24)00556. PubMed
LI T, Zhang Y, Fu F, Chen H, et al The Evolution of the Treatment of Non-small Cell Lung Cancer: A Shift in Surgical
Paradigm to A More Individualized Approach.
J Thorac Cardiovasc Surg. 2024 Jul 25:S0022-5223(24)00655. PubMed
SMITH R JR, Gee KN, Kalvapudi S, Pachimatla A, et al Sex-based Differences in the Lung Immune Microenvironment Are Associated with an
Increased Risk of Lung Cancer in Women.
J Thorac Cardiovasc Surg. 2024 Jul 15:S0022-5223(24)00617. PubMedAbstract available
WATKINS AA, Rizvi TZ, Lopez E, Shehata D, et al Trends and Comparative Outcomes Between Operative Approaches for Segmentectomy in
Lung Cancer.
J Thorac Cardiovasc Surg. 2024 Jul 11:S0022-5223(24)00605. PubMedAbstract available
LIN Y Accurate predictor of occult mediastinal nodal metastasis in stage I lower-lobe
non-small cell lung cancer.
J Thorac Cardiovasc Surg. 2024 Jul 5:S0022-5223(24)00381. PubMed
TSUBOKAWA N, Mimae T, Saeki A, Miyata Y, et al Feasibility and Comparative Prognosis of Segmentectomy vs. Lobectomy in Centrally
Located Small and Solid Dominant cN0 Non-Small Cell Lung Cancer.
J Thorac Cardiovasc Surg. 2024 Jul 3:S0022-5223(24)00538. PubMedAbstract available
MACBETH F, Williams N, Ahmad I, Treasure T, et al Lung surveillance following colorectal cancer pulmonary metastasectomy:
Utilization of clinicopathologic risk factors to guide strategy.
J Thorac Cardiovasc Surg. 2024;168:e10-e11. PubMed
ANTONOFF MB, Kui N, Sun R, Deboever N, et al Factors associated with receipt of pulmonary metastasectomy in patients with
lung-limited metastatic colorectal cancer: Disparities in care and impact on
overall survival.
J Thorac Cardiovasc Surg. 2024;168:263-271. PubMedAbstract available
June 2024
HUTCHINGS H, Wang A, Grady S, Popoff A, et al Influence of Air Quality on Lung Cancer in People Who Have Never Smoked.
J Thorac Cardiovasc Surg. 2024 Jun 25:S0022-5223(24)00536. PubMedAbstract available
BOTT MJ Commentary: Cracking the Code: Deciphering Predictors of Treatment Response in
Non-Small Cell Lung Cancer.
J Thorac Cardiovasc Surg. 2024 Jun 13:S0022-5223(24)00527. PubMed
Discussion to: Computational risk model for predicting 2-year malignancy of
pulmonary nodules using demographic and radiographic characteristics.
J Thorac Cardiovasc Surg. 2024;167:1925-1926. PubMed
SARNAIK KS, Linden PA, Gasnick A, Bassiri A, et al Computational risk model for predicting 2-year malignancy of pulmonary nodules
using demographic and radiographic characteristics.
J Thorac Cardiovasc Surg. 2024;167:1910-1924. PubMedAbstract available
May 2024
YAN H, Niimi T, Matsunaga T, Fukui M, et al Preoperatively Predicting Survival Outcome for Clinical Stage IA Pure-Solid
Non-Small Cell Lung Cancer by Radiomics-based Machine Learning.
J Thorac Cardiovasc Surg. 2024 May 22:S0022-5223(24)00441. PubMedAbstract available
XU L, Si H, Zhuang F, Li C, et al Predicting therapeutic response to neoadjuvant immunotherapy based on an
integration model in resectable stage IIIA (N2) non-small cell lung cancer.
J Thorac Cardiovasc Surg. 2024 May 17:S0022-5223(24)00437. PubMedAbstract available
HSU DS, Kneuertz PJ Commentary: "HIIT"ing the Jackpot with Prehabilitation before Minimally Invasive
Lung Cancer Surgery.
J Thorac Cardiovasc Surg. 2024 May 3:S0022-5223(24)00374. PubMed
JONES DR, Bueno R, Harpole DH Jr, Vaporciyan AA, et al Thoracic Surgical Oncology Group: An American Association for Thoracic Surgery
Clinical Trials Initiative.
J Thorac Cardiovasc Surg. 2024;167:1584-1588. PubMed
April 2024
ZHOU N, Ripley-Gonzalez JW, Zhang W, Xie K, et al Preoperative Exercise Training Decreases Complications of Minimally Invasive Lung
Cancer Surgery- A Randomized Controlled Trial.
J Thorac Cardiovasc Surg. 2024 Apr 11:S0022-5223(24)00296. PubMedAbstract available
ODEH AM, Perez-Tamayo RA, Abdelsattar ZM A wedge is still better than stereotactic body radiation therapy in the national
cancer database.
J Thorac Cardiovasc Surg. 2024;167:e100-e101. PubMed
KIM AT, Ding L, Lee HB, Ashbrook MJ, et al Longer hospitalizations, more complications, and greater readmissions for
patients with comorbid psychiatric disorders undergoing pulmonary lobectomy.
J Thorac Cardiovasc Surg. 2024;167:1502-1511. PubMedAbstract available
March 2024
RUSCH VW Commentary: "Real world" neoadjuvant immunochemotherapy for lung
cancer:Additional data but still many questions.
J Thorac Cardiovasc Surg. 2024 Mar 14:S0022-5223(24)00209. PubMed
KRISTENSON K, Hedman K Percent predicted peak oxygen uptake is superior to weight-indexed peak oxygen
uptake in risk stratification before lung cancer lobectomy.
J Thorac Cardiovasc Surg. 2024 Mar 5:S0022-5223(24)00187. PubMedAbstract available
Discussion to: AATS 2023: Empiric flap coverage for the pneumonectomy stump: How
protective is it? A single-institution cohort study.
J Thorac Cardiovasc Surg. 2024;167:859-860. PubMed
Discussion to: Extent of surgical resection for radiologically subsolid T1N0
invasive lung adenocarcinoma: When is a wedge resection acceptable?
J Thorac Cardiovasc Surg. 2024;167:810-811. PubMed
STEIMER D, Coughlin JM, Yates E, Xie Y, et al Empiric flap coverage for the pneumonectomy stump: How protective is it? A
single-institution cohort study.
J Thorac Cardiovasc Surg. 2024;167:849-858. PubMedAbstract available
SACHDEVA UM Commentary: The genes stand alone: Genetic risk factors predict early pulmonary
recurrence of colorectal carcinoma metastases.
J Thorac Cardiovasc Surg. 2024;167:820-821. PubMed
DEBOEVER N, Bayley EM, Eisenberg MA, Hofstetter WL, et al Lung surveillance following colorectal cancer pulmonary metastasectomy:
Utilization of clinicopathologic risk factors to guide strategy.
J Thorac Cardiovasc Surg. 2024;167:814-819. PubMedAbstract available
ZHANG C, Pan Y, Li H, Zhang Y, et al Extent of surgical resection for radiologically subsolid T1N0 invasive lung
adenocarcinoma: When is a wedge resection acceptable?
J Thorac Cardiovasc Surg. 2024;167:797-809. PubMedAbstract available
February 2024
COOPER A, Chaft JE, Bott MJ Induction Therapy for Non-Small Cell Lung Cancer.
J Thorac Cardiovasc Surg. 2024 Feb 12:S0022-5223(24)00160. PubMed
Discussion to: Surgical outcomes after chemotherapy plus nivolumab and
chemotherapy plus nivolumab and ipilimumab in patients with non-small cell lung
cancer.
J Thorac Cardiovasc Surg. 2024 Feb 10:S0022-5223(24)00022. PubMed
KOREVAAR DA, Annema JT Targeted versus systematic nodal staging in early-stage lung cancer.
J Thorac Cardiovasc Surg. 2024 Feb 8:S0022-5223(24)00004. PubMed
CALL S, Reig-Oussedik N, Obiols C, Sanz-Santos J, et al Video-assisted mediastinoscopic lymphadenectomy (VAMLA): mature results for
staging non-small cell lung cancer with normal mediastinum.
J Thorac Cardiovasc Surg. 2024 Feb 2:S0022-5223(24)00098. PubMedAbstract available
ZHANG X, Tsauo J, Tian P, Zhao L, et al Randomized comparison of the four-hook anchor device and hook-wire use for the
preoperative localization of pulmonary nodules.
J Thorac Cardiovasc Surg. 2024;167:498-507. PubMedAbstract available
January 2024
Discussion to: National enrollment of lung cancer clinical trials is
disproportionate based on race and health care access.
J Thorac Cardiovasc Surg. 2024 Jan 27:S0022-5223(23)01209. PubMed
MARTIN TK, Dinerman A, Sudhaman S, Budde G, et al Early real-world experience monitoring circulating tumor DNA in resected
early-stage non-small cell lung cancer.
J Thorac Cardiovasc Surg. 2024 Jan 18:S0022-5223(24)00075. PubMedAbstract available
FUKUI M, Matsunaga T, Hattori A, Takamochi K, et al Prognostic significance of preoperative exercise tolerance in patients with
early-stage lung cancer.
J Thorac Cardiovasc Surg. 2024 Jan 11:S0022-5223(24)00006. PubMedAbstract available
LIN N, Berry MF Commentary: Re-consult surgery for lung cancer patients? The role of resection
after initial non-operative therapy.
J Thorac Cardiovasc Surg. 2024 Jan 9:S0022-5223(24)00007. PubMed
TOHMASI S, Puri V Commentary: Segmentectomy versus lobectomy: Are the findings of the JCOG 0802 and
CALGB 140503 trials generalizable to the US population?
J Thorac Cardiovasc Surg. 2024;167:365-366. PubMed
POTTER AL, Kim J, McCarthy ML, Senthil P, et al Segmentectomy versus lobectomy in the United States: Outcomes after resection for
first primary lung cancer and treatment patterns for second primary lung cancers.
J Thorac Cardiovasc Surg. 2024;167:350-364. PubMedAbstract available
December 2023
Discussion to: Preoperative predictors of spread through air spaces in lung
cancer.
J Thorac Cardiovasc Surg. 2023 Dec 27:S0022-5223(23)01119. PubMed
Discussion to: Lung resection after initial nonoperative treatment for non-small
cell lung cancer.
J Thorac Cardiovasc Surg. 2023 Dec 27:S0022-5223(23)01129. PubMed
KWAK M, Bassiri A, Jiang B, Sinopoli J, et al National enrollment of lung cancer clinical trials is disproportionate based on
race and health care access.
J Thorac Cardiovasc Surg. 2023 Dec 18:S0022-5223(23)01199. PubMedAbstract available
SAKOWITZ S, Bakhtiyar SS, Curry J, Ali K, et al Association of Neighborhood Socioeconomic Disadvantage with Utilization of
Minimally Invasive Resection for Non-Small Cell Lung Cancer.
J Thorac Cardiovasc Surg. 2023 Dec 13:S0022-5223(23)01195. PubMedAbstract available
DONINGTON J, Hu X, Zhang S, Song Y, et al Event-Free Survival as a Predictor of Overall Survival and Recurrence Burden of
Patients with Non-Small Cell Lung Cancer Receiving Neoadjuvant Therapy.
J Thorac Cardiovasc Surg. 2023 Dec 11:S0022-5223(23)01193. PubMedAbstract available
SERVAIS EL Commentary: Utilization and equity in lung cancer screening: time to abandon the
one-size-fits-all approach?
J Thorac Cardiovasc Surg. 2023 Dec 4:S0022-5223(23)01122. PubMed
Discussion to: Superior sulcus non-small cell lung cancers (Pancoast tumors):
Current outcomes after multidisciplinary management.
J Thorac Cardiovasc Surg. 2023;166:1488-1489. PubMed
MCLAUGHLIN K, Tan KS, Dycoco J, Chen MF, et al Superior sulcus non-small cell lung cancers (Pancoast tumors): Current outcomes
after multidisciplinary management.
J Thorac Cardiovasc Surg. 2023;166:1477-1487. PubMedAbstract available
CAO H, Ma Z, Li Y, Zhang Y, et al Prognostic value of KRAS G12C mutation in lung adenocarcinoma stratified by
stages and radiological features.
J Thorac Cardiovasc Surg. 2023;166:e479-e499. PubMedAbstract available
SARKARIA IS, Martin LW, Rice DC, Blackmon SH, et al Pafolacianine for intraoperative molecular imaging of cancer in the lung: The
ELUCIDATE trial.
J Thorac Cardiovasc Surg. 2023;166:e468-e478. PubMedAbstract available
November 2023
DUNNE EG, Fick CN, Tan KS, Toumbacaris N, et al Lung Resection After Initial Nonoperative Treatment for Non-Small Cell Lung
Cancer.
J Thorac Cardiovasc Surg. 2023 Nov 30:S0022-5223(23)01116. PubMedAbstract available
Discussion to: Induction chemoimmunotherapy with surgery versus concurrent
chemoradiation followed by immunotherapy for stage III-N2 non-small cell lung
cancer.
J Thorac Cardiovasc Surg. 2023 Nov 28:S0022-5223(23)00992. PubMed
TASNIM S, Raja S, Mukhopadhyay S, Blackstone EH, et al Preoperative Predictors of Spread Through Air Spaces (STAS) in Lung Cancer.
J Thorac Cardiovasc Surg. 2023 Nov 23:S0022-5223(23)01106. PubMedAbstract available
MANIWA T, Okami J, Miyoshi T, Wakabayashi M, et al Lymph node dissection in small peripheral lung cancer: supplemental analysis of
JCOG0802/WJOG4607L.
J Thorac Cardiovasc Surg. 2023 Nov 22:S0022-5223(23)01099. PubMedAbstract available
DYAS AR, Bronsert MR, Stuart CM, Thomas MB, et al Analyzing the Impact of the COVID-19 Pandemic on Initial Oncologic Presentation
and Treatment of Non-Small Cell Lung Cancer in the United States.
J Thorac Cardiovasc Surg. 2023 Nov 17:S0022-5223(23)01098. PubMedAbstract available
SULLIVAN KA, Farrokhyar F, Patel YS, Liberman M, et al Preoperative Mediastinal Staging in Early-Stage Lung Cancer: Targeted Nodal
Sampling is Not Inferior to Systematic Nodal Sampling.
J Thorac Cardiovasc Surg. 2023 Nov 17:S0022-5223(23)01096. PubMedAbstract available
Discussion to: Association of socioeconomic factors with the receipt of
neoadjuvant therapy for patients with non-small cell lung cancer.
J Thorac Cardiovasc Surg. 2023 Nov 17:S0022-5223(23)00979. PubMed
Discussion to AATS 2023: Exposure to Agent Orange is associated with increased
recurrence after surgical treatment of stage I non-small cell lung cancer.
J Thorac Cardiovasc Surg. 2023 Nov 9:S0022-5223(23)00904. PubMed
AL-THANI S, Nasar A, Villena-Vargas J, Chow O, et al Should Sampling of Three N2 Stations be a Quality Metric for Curative Resection
of Stage I Lung Cancer?
J Thorac Cardiovasc Surg. 2023 Nov 3:S0022-5223(23)01015. PubMedAbstract available
SEPESI B, Mehran R, Spicer J, Cascone T, et al Neostar Trial and The Current Status of Neoadjuvant Therapy in Non-Small Cell
Lung Cancer.
J Thorac Cardiovasc Surg. 2023 Nov 1:S0022-5223(23)01012. PubMed
October 2023
Discussion to: Quality improvement mechanisms to improve lymph node staging for
lung cancer: Trends from a statewide database.
J Thorac Cardiovasc Surg. 2023 Oct 20:S0022-5223(23)00865. PubMed
Discussion to: Overall survival in low-comorbidity patients with stage I
non-small cell lung cancer who chose stereotactic body radiotherapy compared to
surgery.
J Thorac Cardiovasc Surg. 2023 Oct 20:S0022-5223(23)00867. PubMed
REDDY RM Commentary: Neoadjuvant Immunotherapy followed by Lung Cancer Resection: Is the
Future Already Here?
J Thorac Cardiovasc Surg. 2023 Oct 18:S0022-5223(23)00980. PubMed
POTTER AL, Senthil P, Srinivasan D, Raman V, et al Persistent Racial and Sex-based Disparities in Lung Cancer Screening Eligibility.
J Thorac Cardiovasc Surg. 2023 Oct 18:S0022-5223(23)00981. PubMedAbstract available
WOLF AS Commentary: Nothing is free: Surgeons' and radiation oncologists' biases about
treating early stage lung cancer in healthy patients.
J Thorac Cardiovasc Surg. 2023 Oct 17:S0022-5223(23)00986. PubMed
KAMTAM DN, Shrager JB We should be considering lung cancer screening for never-smoking Asian-American
females.
J Thorac Cardiovasc Surg. 2023 Oct 14:S0022-5223(23)00976. PubMed
FELDMAN H, Sepesi B, Leung CH, Lin H, et al Surgical Outcomes After Chemotherapy plus Nivolumab and Chemotherapy plus
Nivolumab and Ipilimumab in Patients with Non-Small Cell Lung Cancer.
J Thorac Cardiovasc Surg. 2023 Oct 8:S0022-5223(23)00900. PubMedAbstract available
YOSHINO I, Moriya Y, Suzuki K, Wakabayashi M, et al Long-term outcome of patients with peripheral ground-glass opacity-dominant lung
cancer after sublobar resections.
J Thorac Cardiovasc Surg. 2023;166:1222-1231. PubMedAbstract available
STEIMER D, Ugalde Figueroa P Commentary: Sublobar resection for ground-glass opacity: Is less really more?
J Thorac Cardiovasc Surg. 2023;166:1232-1233. PubMed
September 2023
Discussion to: Perspectives, risk factors, and coping mechanisms in patients with
self-reported financial burden following lung cancer surgery.
J Thorac Cardiovasc Surg. 2023 Sep 30:S0022-5223(23)00783. PubMed
ANTONOFF MB, Deboever N, Werner R, Altan M, et al Surgery for Oligometastatic Non-Small Cell Lung Cancer.
J Thorac Cardiovasc Surg. 2023 Sep 29:S0022-5223(23)00874. PubMedAbstract available
ELBAHRAWY MM, Kamel MK, Rodriguez-Quintero JH, Vimolratana M, et al Association of Socioeconomic Factors with the Receipt of Neoadjuvant Therapy for
Patients with Non-Small Cell Lung Cancer.
J Thorac Cardiovasc Surg. 2023 Sep 21:S0022-5223(23)00857. PubMedAbstract available
KUMAR A, Srinivasan D, Potter A, Mathey-Andrews C, et al Induction Chemoimmunotherapy with Surgery versus Concurrent Chemoradiation
followed by Immunotherapy for Stage III-N2 Non-small Cell Lung Cancer.
J Thorac Cardiovasc Surg. 2023 Sep 16:S0022-5223(23)00853. PubMedAbstract available
POTTER AL, Rosenstein AL, Kandala K, Venkateswaran S, et al Shortage of Thoracic Surgeons in the United States: Implications for Treatment
and Survival for Stage I Lung Cancer Patients.
J Thorac Cardiovasc Surg. 2023 Sep 14:S0022-5223(23)00796. PubMedAbstract available
SUBRAMANIAN MP, Eaton DB Jr, Labilles UL, Heiden BT, et al Exposure to Agent Orange is Associated with Increased Recurrence after Surgical
Treatment of Stage I Non-Small Cell Lung Cancer.
J Thorac Cardiovasc Surg. 2023 Sep 12:S0022-5223(23)00788. PubMedAbstract available
EISENBERG MA, Deboever N, Mills AC, Egyud MR, et al Impact of Travel Distance on Receipt of Indicated Adjuvant Therapy in Resected
Non-Small Cell Lung Cancer.
J Thorac Cardiovasc Surg. 2023 Sep 9:S0022-5223(23)00765. PubMedAbstract available
August 2023
ALTORKI NK, Chow OS Cancer and Leukemia Group B 140503: Is it time to turn the page on Lung Cancer
Study Group 821?
J Thorac Cardiovasc Surg. 2023 Aug 18:S0022-5223(23)00725. PubMed
March 2023
D'AMICO TA Japanese Oncology Group 0802: Another giant leap.
J Thorac Cardiovasc Surg. 2023;165:873-875. PubMed
CHEN Z, Bernards N, Gregor A, Vannelli C, et al Anatomic evaluation of Pancoast tumors using three-dimensional models for
surgical strategy development.
J Thorac Cardiovasc Surg. 2023;165:842-852. PubMedAbstract available
INRA ML, Wasserman GA, Karp J, Cohen S, et al Improvement in postoperative lung function in patients with moderate to severe
airway obstruction after robotic-assisted thoracoscopic tracheobronchoplasty.
J Thorac Cardiovasc Surg. 2023;165:876-885. PubMedAbstract available
ZHOU D, Gao Y, Wang H, Xin H, et al Prevalence and anatomical characteristics of subsuperior segment in lung lower
lobe.
J Thorac Cardiovasc Surg. 2023;165:864-872. PubMedAbstract available
PEREZ HOLGUIN RA, Olecki EJ, Wong WG, Stahl KA, et al Outcomes after sublobar resection versus lobectomy in non-small cell carcinoma in
situ.
J Thorac Cardiovasc Surg. 2023;165:853-861. PubMedAbstract available
BERTOLACCINI L, Spaggiari L Commentary: The sublobar resections and the difference between a conjecture and a
theorem.
J Thorac Cardiovasc Surg. 2023;165:862-863. PubMed